Coroidopatía serosa central versus oftalmía simpática: A propósito de un caso

Gómez-Valcárcel, María; Sinisterra-Pava, JP; Arellanes-García, Lourdes

doi:10.4321/s0365-66912004001000007

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multifocal choroiditis (Gass & Little 1995), uveal effusion syndrome, sympathetic ophthalmia (Gomez‐Valcarcel et al. 2004) and other posterior pole inflammatory or infectious processes may be associated with serous retinal detachment.…”

Section: Differential Diagnosismentioning

confidence: 99%

Central serous chorioretinopathy

Wang

Munch

Hasler

et al. 2008

Acta Ophthalmologica

587

521

View full text Add to dashboard Cite

ABSTRACT.Central serous chorioretinopathy (CSC) is a disease of the retina characterized by serous detachment of the neurosensory retina secondary to one or more focal lesions of the retinal pigment epithelium (RPE). CSC occurs most frequently in mid-life and more often in men than in women. Major symptoms are blurred vision, usually in one eye only and perceived typically by the patient as a dark spot in the centre of the visual field with associated micropsia and metamorphopsia. Normal vision often recurs spontaneously within a few months. The condition can be precipitated by psychosocial stress and hypercortisolism. Ophthalmoscopic signs of CSC range from mono-or paucifocal RPE lesions with prominent elevation of the neurosensory retina by clear fluid -typical of cases of recent onset -to shallow detachments overlying large patches of irregularly depigmented RPE. The spectrum of lesions includes RPE detachments. Granular or fibrinous material may accumulate in the subretinal cavity. Serous detachment often resolves spontaneously. From first contact, counselling about the potential relation to stress and glucocorticoid medication is warranted. After 3 months without resolution of acute CSC or in chronic CSC, treatment should be considered. Resolution of detachment can usually be achieved in acute CSC by focal photocoagulation of leaking RPE lesions or, in chronic CSC, by photodynamic therapy. The effect of therapy on long-term visual outcome is insufficiently documented. Reattachment within 4 months of onset is considered a relevant therapeutic target because prolonged detachment is associated with photoreceptor atrophy. This suggests that the value of treatment depends upon proper selection of cases that will not resolve without therapy. Chronic CSC may be difficult to differentiate from occult choroidal neovascularization secondary to CSC. Patients with chronic CSC who receive glucocorticoid treatment for systemic disease can often be managed without having to discontinue this medication.

show abstract

Section: Differential Diagnosismentioning

confidence: 99%

Central serous chorioretinopathy

Wang

Munch

Hasler

et al. 2008

Acta Ophthalmologica

587

521

View full text Add to dashboard Cite

show abstract

Central Serous Chorioretinopathy, Corticosteroids, and Uveitis

Khairallah

Kahloun

Tuğal-Tutkun

2012

Ocular Immunology and Inflammation

View full text Add to dashboard Cite

Any patient with a diagnosis of central serous chorioretinopathy (CSCR) should be questioned to determine any recent corticosteroid use, as the poor visual outcome may be due to unrecognized corticosteroid use. Atypical forms of CSCR may be misdiagnosed as an inflammatory serous retinal detachment, mainly Vogt-Koyanagi-Harada disease. CSCR that develops in association with preexisting uveitis could be a challenging diagnosis as it might be misinterpreted as a worsening of the primary inflammatory condition. Failure to differentiate CSCR from retinal or choroidal inflammatory diseases may result in inappropriate use of corticosteroids, leading to exacerbation of the condition and permanent visual loss. Discontinuation of corticosteroids should be the first step in the treatment of CSCR associated with corticosteroid therapy, and the use of immunosuppressive or immunomodulatory drugs may be required to control systemic or ocular inflammatory disease. The prognosis is usually favorable, but persistent visual loss may occur.

show abstract

Coroidopatía serosa central versus oftalmía simpática: A propósito de un caso

Abstract: The association of stress, anxious personality, and steroid use can favor atypical presentations of central serous chorioretinopathy.

Cited by 2 publications

References 0 publications

Central serous chorioretinopathy

Central serous chorioretinopathy

Central Serous Chorioretinopathy, Corticosteroids, and Uveitis

Contact Info

Product

Resources

About